Surgical Sealants, Glues, Sutures/Clips, Hemostats Outside the U.S.

1 Min Read

The world market for the securement products, encompassing wound closure/sealing, hemostasis and anti-adhesion) is currently valued at more than $9.7 billion. This total market is growing at a steady 6.7% compound annual rate, though growth rates for individual regions vary. 

Average growth in the world closure and securement products market also reflects differing conditions in individual countries, ranging between 3% CAGR for less developed economies and considerably higher for the United States.

The world market for the securement products, encompassing wound closure/sealing, hemostasis and anti-adhesion) is currently valued at more than $9.7 billion. This total market is growing at a steady 6.7% compound annual rate, though growth rates for individual regions vary. 

Average growth in the world closure and securement products market also reflects differing conditions in individual countries, ranging between 3% CAGR for less developed economies and considerably higher for the United States.

Below is illustrated the market value and compound annual growth rate of the closure and securement market for countries outside the U.S. (the U.S. dominates the world market, largely dwarfing non-U.S. markets).

 

Securement-size-growth

 

Source: MedMarket Diligence Report #S180; “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015.”


     

Share This Article
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version